It will be interesting in future studies to perform single-cell RNA sequencing (scRNA-seq) analysis to further characterize the molecular mechanisms involved in the remodeling of tumor endothelial cells during anti-CTLA-4 therapy. The gene discussed is CTLA4; the disease is neoplasm.